Price target upside
Generate Biomedicines, Inc. Price Target Upside or Downside
GENB price target upside based on the current price and analyst average.
Direct answer
Generate Biomedicines, Inc.'s analyst target implies +79.4%.
The average target is $25.60 compared with a recorded current price of $14.27.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Generate Biomedicines, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $14.27
- Average price target
- $25.60
- High price target
- $30.00
- Low price target
- $22.00
- Target upside
- +79.4%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026